These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1206 related articles for article (PubMed ID: 17320663)
21. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder. Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737 [TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience. Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115 [TBL] [Abstract][Full Text] [Related]
25. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911. Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466 [TBL] [Abstract][Full Text] [Related]
26. Effect of intravesical instillation on performance of uCYT+ test. Lodde M; Mian C; Negri G; Vittadello F; Comploj E; Palermo S; Staffler A; Brössner C; Pycha A Urology; 2004 May; 63(5):878-81. PubMed ID: 15134970 [TBL] [Abstract][Full Text] [Related]
28. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. Brake M; Loertzer H; Horsch R; Keller H J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163 [TBL] [Abstract][Full Text] [Related]
29. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080 [TBL] [Abstract][Full Text] [Related]
30. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor]. Ikegami S; Tsuji A; Suzuki S; Sumitomo M; Kimura F; Asano T; Nakajima F; Hayakawa M Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314 [TBL] [Abstract][Full Text] [Related]
31. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer. Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798 [TBL] [Abstract][Full Text] [Related]
32. The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer. Guevara A; Salomon L; Allory Y; Ploussard G; de la Taille A; Paul A; Yiou R; Hoznek A; Dahan M; Abbou CC; Vordos D J Urol; 2010 Jun; 183(6):2161-4. PubMed ID: 20399454 [TBL] [Abstract][Full Text] [Related]
34. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ. Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389 [TBL] [Abstract][Full Text] [Related]
35. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin. Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562 [TBL] [Abstract][Full Text] [Related]
36. The management of superficial bladder cancer. Dalbagni G Nat Clin Pract Urol; 2007 May; 4(5):254-60. PubMed ID: 17483810 [TBL] [Abstract][Full Text] [Related]
37. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E; Iborra I; Rubio J; Casanova J; Almenar S BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101 [TBL] [Abstract][Full Text] [Related]
38. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related]
39. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer. Demkow T; Alter A; Wiechno P Urol Int; 2008; 80(1):74-9. PubMed ID: 18204238 [TBL] [Abstract][Full Text] [Related]
40. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. Andius P; Holmäng S BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]